Pharmaceuticals - Mumbai, Maharashtra, India
In 1988, the group bought Nicholas Laboratories, the company which later flourished and by 2010 reached the highest valuation in the pharmaceutical industry. Over the decade, the company acquired many business units to strengthen their presence. In 2006, the company bought Pfizer's UK manufacturing facility, Morpeth. The company also formed Piramal foundation, a philanthropic arm of the group.In the year 1999 Piramal Glass acquired Ceylon Company Ltd, Sri Lanka. The year 2006 saw Piramal Healthcare being listed as a global leader by S&P Global Challengers. Piramal also acquired Pfizer's Morpeth UK facility.In 2007, it underwent a deal with Merck for development and discovery of new drugs. In 2008, it signed second drug development deal with Eli Lilly. The company Nicholas Laboratories was renamed to Piramal Healthcare Ltd. In 2010, the domestic formulations business was sold to Abbott. It was considered to the most expensive deal. In the same year, the group formed its own real estate entity, Piramal Realty.2011 saw Fortune 500 ranking Piramal Healthcare in the top-50 largest corporations across India. Also, UN Conference on Trade and Development's World Investment Report 2011 ranked Piramal Healthcare as No. 5 in the top 10 pharmaceutical contract manufacturers worldwide.